Abstract
C‐peptide is secreted in equimolar concentrations with insulin, and is often measured to assess pancreatic β‐cell function. C‐peptide analysis is most often performed by radioimmunoassay (RIA) which has several disadvantages. We evaluated an automated, chemiluminescent immunoassay for C‐peptide in terms of precision, linearity, interference, and correlation with a RIA method. The chemiluminescent assay demonstrated acceptable correlation with the RIA method (slope = 0.82, y‐intercept = 0.88 ng/ml, r‐value = 0.97). Between‐run Cvs ranged from 8 to 9%, which compared well with the RIA method. Linearity extended beyond the manufacturer's recommendations and recovery ranged from 87 to 112% across the concentrations tested, with a slope of 1.007. No significant interference was noted with hemoglobin, bilirubin, or triglyceride. Overall this method compared favorably with the RIA method and offers an alternative to RIA for the analysis of C‐peptide. J. Clin. Lab. Anal. 14:17–19, 2000. © 2000 Wiley‐Liss, Inc.
Keywords: C‐peptide, immunoassay, diabetes, insulin, islets
REFERENCES
- 1. Polonsky KS. The β‐cell in diabetes: from molecular genetics to clinical research. Diabetes 1995;44:705–717. [DOI] [PubMed] [Google Scholar]
- 2. Steiner DF Rubenstein AH. Proinsulin C‐peptide‐biological activity? Science 1997;277:531–532. [DOI] [PubMed] [Google Scholar]
- 3. Forst T, Kunt T, Pohlmann T, et al. Biological activity of C‐peptide on the skin microcirculation in patients with insulin‐dependent diabetes mellitus. J Clin Invest 1998;101:2036–2041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Polonsky KS, Pugh W, Jaspan JB, et al. C‐peptide and insulin secretion: relationship between peripheral concentrations of C‐peptide and insulin and their secretion rates in the dog. J Clin Invest 1984;74:1821–1829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Licinio‐Paixao J, Polonsky KS, Given BD, et al. Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C‐peptide. J Clin Endocrinol Metab 1986;63:401–403. [DOI] [PubMed] [Google Scholar]
- 6. Faber Ok, Hagen C, Binder C, et al. Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978;62:197–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Polonsky KS, Licinio‐Paixao J, Given BD, et al. Use of biosynthetic human C‐peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 1986;77:98–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Chaturvedi D, Unver E, Lei J‐D, et al. Highly sensitive and specific automated chemiluminescent enzyme immunoassay for C‐peptide. Clin Chem 1995;41:S68–S69(abstr.158). [Google Scholar]
- 9. Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry Philadelphia:W.B. Saunders Co; 1999. 1808 p. [Google Scholar]